Work Package 1
Technological and Clinical Value Factors
- To develop evidence-based clinical algorithms for community acquired-acute respiratory tract infections CA-ARTI and assess the diagnostic accuracy and the clinical utility of point-of-care tests (POCT) for specific groups of patients, clinical findings, and settings
- To develop evidence-based URS’s to support future development and implementation of rapid diagnostics to reduce antimicrobial resistance (AMR) for CA-ARTI, and to refine the methods and processes to make them applicable to POC diagnostic developments for other infectious disease indications
- To create a technical roadmap that incorporates recommendations for short- and long-term goals to help companies and research institutions prioritize investment decisions in the field of CA-ARTI diagnostics.